Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/14966
DC FieldValueLanguage
dc.contributor.authorKiernan, Urban Aen_US
dc.contributor.authorPhillips, David Aen_US
dc.contributor.authorTrenchevska, Olgicaen_US
dc.contributor.authorNedelkov, Dobrinen_US
dc.date.accessioned2021-09-29T06:48:05Z-
dc.date.available2021-09-29T06:48:05Z-
dc.date.issued2011-03-30-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/14966-
dc.description.abstractRetinol Binding Protein 4 (RBP4) is an exciting new biomarker for the determination of insulin resistance and type 2 diabetes. It is known that circulating RBP4 resides in multiple variants which may provide enhanced clinical utility, but conventional immunoassay methods are blind to such differences. A Mass Spectrometric immunoassay (MSIA) technology that can quantitate total RBP4 as well as individual isoforms may provide an enhanced analysis for this biomarker.en_US
dc.language.isoenen_US
dc.publisherPublic Library of Science (PLoS)en_US
dc.relation.ispartofPloS oneen_US
dc.titleQuantitative mass spectrometry evaluation of human retinol binding protein 4 and related variantsen_US
dc.identifier.doi10.1371/journal.pone.0017282-
dc.identifier.urlhttp://dx.plos.org/10.1371/journal.pone.0017282-
dc.identifier.volume6-
dc.identifier.issue3-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Natural Sciences and Mathematics-
Appears in Collections:Faculty of Natural Sciences and Mathematics: Journal Articles
Прикажи едноставен запис

Page view(s)

50
checked on 10.9.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.